Evaluation of and measures to reduce contamination inside the cancer drug compounding assist system

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: IRISA, Toshihiro (Kyushu University Hospital, Department of Pharmacy, Higashi-ku, Japan)
  • Co-author(s): Toshihiro Irisa:
    Hiroyuki Watanabe: Department of Pharmacy, Kyushu University Hospital, Higashi-ku, Japan
    Kojiro Hata: Department of Pharmacy, Kyushu University Hospital, Higashi-ku, Japan
    Kazue Nakashima: Department of Pharmacy, Kyushu University Hospital, Higashi-ku, Japan
    Satohiro Masuda: Department of Pharmacy, Kyushu University Hospital, Higashi-ku, Japan
  • Abstract:

    Background

    To reduce the risk of occupational exposure to anticancer drugs, we developed the Cancer-Drug Compounding Assist System (CDCAS) in collaboration with Nikka Micron Corporation and Yaskawa Electric Corporation. However, contamination of anti-cancer drugs has been reported in some devices, but it has not been clearly evaluated in CDCAS...

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login